{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:41:38Z","timestamp":1764121298864,"version":"3.46.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA SC 010378","BC 010983"],"award-info":[{"award-number":["ZIA SC 010378","BC 010983"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bneo.2025.100161","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:40:16Z","timestamp":1755654016000},"page":"100161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Azanucleoside treatment leads to B-cell precursor acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"2","author":[{"given":"Vijay","family":"Negi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Tuckey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelin Jack","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Difilippantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Doroshow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-9969","authenticated-orcid":false,"given":"Peter D.","family":"Aplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bneo.2025.100161_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.bneo.2025.100161_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/genes9120620","article-title":"Structural basis of DNMT1 and DNMT3A-Mediated DNA Methylation","volume":"9","author":"Ren","year":"2018","journal-title":"Genes (Basel)"},{"issue":"46","key":"10.1016\/j.bneo.2025.100161_bib3","doi-asserted-by":"crossref","first-page":"48350","DOI":"10.1074\/jbc.M403427200","article-title":"The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites","volume":"279","author":"Hermann","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bneo.2025.100161_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hoc.2010.02.007","article-title":"Epigenetic changes in the myelodysplastic syndrome","volume":"24","author":"Issa","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"15","key":"10.1016\/j.bneo.2025.100161_bib5","first-page":"3730","article-title":"Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia","volume":"59","author":"Melki","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bneo.2025.100161_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajh.20186","article-title":"Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia","volume":"77","author":"Ekmekci","year":"2004","journal-title":"Am J Hematol"},{"issue":"35","key":"10.1016\/j.bneo.2025.100161_bib7","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bneo.2025.100161_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.bneo.2025.100161_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","article-title":"Cancer epigenetics comes of age","volume":"21","author":"Jones","year":"1999","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.bneo.2025.100161_bib10","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quint\u00e1s-Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bneo.2025.100161_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1072651","article-title":"Recent progress in DNA methyltransferase inhibitors as anticancer agents","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bneo.2025.100161_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.acr.2021.03.007","article-title":"DNA methylation inhibitors: retrospective and perspective view","volume":"152","author":"Uddin","year":"2021","journal-title":"Adv Cancer Res"},{"issue":"5","key":"10.1016\/j.bneo.2025.100161_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/theoncologist.2012-0465","article-title":"Concise drug review: azacitidine and decitabine","volume":"18","author":"Derissen","year":"2013","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.bneo.2025.100161_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s43018-021-00271-z","article-title":"The next generation of DNMT inhibitors","volume":"2","author":"Mehdipour","year":"2021","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.bneo.2025.100161_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/jpet.121.000758","article-title":"5-Aza-4'-thio-2'-deoxycytidine, a new orally bioavailable nontoxic \"best-in-class\": DNA methyltransferase 1-depleting agent in clinical development","volume":"379","author":"Parker","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.bneo.2025.100161_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00280-014-2503-z","article-title":"Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine","volume":"74","author":"Thottassery","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15","key":"10.1016\/j.bneo.2025.100161_bib17","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1158\/0008-5472.CAN-23-2785","article-title":"The DNA methyltransferase inhibitor 5-Aza-4'-thio-2'-deoxycytidine induces C>G transversions and acute lymphoid leukemia development","volume":"84","author":"Bertoli","year":"2024","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.bneo.2025.100161_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100161_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.celrep.2018.06.007","article-title":"Immature CD8 single-positive thymocytes are a molecularly distinct subpopulation, selectively dependent on BRD4 for their differentiation","volume":"24","author":"Gegonne","year":"2018","journal-title":"Cell Rep"},{"issue":"23","key":"10.1016\/j.bneo.2025.100161_bib20","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1093\/emboj\/16.23.7019","article-title":"Control of B-cell development by Ras-mediated activation of Raf","volume":"16","author":"Iritani","year":"1997","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.bneo.2025.100161_bib21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.173.5.1213","article-title":"Resolution and characterization of pro-B and pre-pro-B-cell stages in normal mouse bone marrow","volume":"173","author":"Hardy","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.bneo.2025.100161_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2023.07.004","article-title":"Human and mouse early B-cell development: so similar but so different","volume":"261","author":"Korzhenevich","year":"2023","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.bneo.2025.100161_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.it.2022.01.003","article-title":"Unraveling B-cell trajectories at single cell resolution","volume":"43","author":"Morgan","year":"2022","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.bneo.2025.100161_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0145-2126(94)00136-X","article-title":"Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells","volume":"19","author":"Ashley","year":"1995","journal-title":"Leuk Res"},{"issue":"19","key":"10.1016\/j.bneo.2025.100161_bib25","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.7150\/thno.65398","article-title":"Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia","volume":"11","author":"Oliveira","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bneo.2025.100161_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.2019002220","article-title":"Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia","volume":"135","author":"Li","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bneo.2025.100161_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216935","article-title":"Immunosuppressive agents-effects on the cardiovascular system and selected metabolic aspects: a review","volume":"12","author":"Opa\u0142ka","year":"2023","journal-title":"J Clin Med"},{"issue":"6591","key":"10.1016\/j.bneo.2025.100161_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl9283","article-title":"Substitution mutational signatures in whole-genome-sequenced cancers in the UK population","volume":"376","author":"Degasperi","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bneo.2025.100161_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","article-title":"Mutational processes molding the genomes of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100161_bib30","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1038\/s41467-024-54223-z","article-title":"Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes","volume":"15","author":"Silveira","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bneo.2025.100161_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygeno.2005.09.012","article-title":"Sequence context analysis in the mouse genome: single nucleotide polymorphisms and CpG island sequences","volume":"87","author":"Zhao","year":"2006","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.bneo.2025.100161_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5858\/2007-131-185-DOCIGR","article-title":"Detection of clonal IGH gene rearrangements: summary of molecular oncology surveys of the College of American Pathologists","volume":"131","author":"Nikiforova","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"24","key":"10.1016\/j.bneo.2025.100161_bib33","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood.2018864173","article-title":"Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background","volume":"133","author":"Yin","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2025.100161_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bneo.2025.100161_bib35","series-title":"Ovarian Cancer: Methods and Protocols","first-page":"83","article-title":"Bisulfite sequencing of cloned alleles","author":"Huang","year":"2013"},{"issue":"9","key":"10.1016\/j.bneo.2025.100161_bib36","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1073\/pnas.94.9.4681","article-title":"Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase","volume":"94","author":"Jackson-Grusby","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.bneo.2025.100161_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","article-title":"Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia","volume":"2","author":"Pappalardi","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.bneo.2025.100161_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2020.07.010","article-title":"\u201cCaught in the net\u201d: the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia","volume":"89","author":"Zanetti","year":"2020","journal-title":"Exp Hematol"},{"issue":"26","key":"10.1016\/j.bneo.2025.100161_bib39","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bneo.2025.100161_bib40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1182\/blood-2011-02-338848","article-title":"Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice","volume":"118","author":"van der Weyden","year":"2011","journal-title":"Blood"},{"issue":"51","key":"10.1016\/j.bneo.2025.100161_bib41","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1038\/sj.onc.1208931","article-title":"Defining the oncogenic function of the TEL\/AML1 (ETV6\/RUNX1) fusion protein in a mouse model","volume":"24","author":"Fischer","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bneo.2025.100161_bib42","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1158\/0008-5472.CAN-07-0075","article-title":"Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation","volume":"67","author":"Slape","year":"2007","journal-title":"Cancer Res"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:39:47Z","timestamp":1764121187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2950328025000962"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100161","relation":{},"ISSN":["2950-3280"],"issn-type":[{"type":"print","value":"2950-3280"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azanucleoside treatment leads to B-cell precursor acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":".","name":"copyright","label":"Copyright"}],"article-number":"100161"}}